Review




Structured Review

Proteintech ul22
Figure 3. N-bNAC Probes Nascent Chains inside the Ribosomal Tunnel (A) cryo-EM reconstruction of C. elegans NAC∙60S. (Left) Cross section of the map to better visualize the NAC density in the tunnel is shown. (Right) Close-up view of the NAC density in the tunnel that reaches the constriction formed by the extension of <t>uL22</t> is shown. The resolution of the NAC density inside the ribosomal tunnel is 6–8 A˚ . The map was low-pass filtered to 4.2-A˚ resolution. The residues R126 of uL22 and R28 of eL39 shown in the stick model were substituted with Bpa in the analyses shown in (C) and Figures S5A–S5C. (B) Site-specific photo-crosslinking of different Bpa-NAC variants (see Figure S4A) to stalled ribosome-nascent chain complexes (RNCs) car- rying in vitro translated, S35-labeled NCs with defined length (10–50 aas; translated substrate = human glucose-6-phosphate isomerase [GPI]). Autoradiograph images are shown. The peptidyl- tRNA (NC-tRNA) and position-specific NC-tRNA- NAC crosslinks (arrowheads) are indicated. (C) Engineered yeast 60S ribosomes carrying Bpa at tunnel-wall-lining position R126 of FLAG-uL22, indicated in (A), were photo-crosslinked to purified human and C. elegans (C.e.) NAC. WT-NAC as well as NAC deletion mutants lacking the N-terminal aNAC domain (C. elegans DN1–53 and human DN1–67) were used. FLAG, aNAC, and bNAC im- munoblots are shown. Red arrowheads indicate bNAC-specific crosslinks. Asterisk on FLAG blot marks a NAC-independent intra-60S ribosomal crosslink. See also Figures S5A–S5C. (D) Human NAC carrying Bpa at position 2 of bNAC (b-X2) was photo-crosslinked to puromycin- washed empty 60S or untreated full 80S. eL22, uL22, and eL39 immunoblots are shown. See also Figures S4 and S5.
Ul22, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 11 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ul22/product/Proteintech
Average 93 stars, based on 11 article reviews
ul22 - by Bioz Stars, 2026-03
93/100 stars

Images

1) Product Images from "Early Scanning of Nascent Polypeptides inside the Ribosomal Tunnel by NAC."

Article Title: Early Scanning of Nascent Polypeptides inside the Ribosomal Tunnel by NAC.

Journal: Molecular cell

doi: 10.1016/j.molcel.2019.06.030

Figure 3. N-bNAC Probes Nascent Chains inside the Ribosomal Tunnel (A) cryo-EM reconstruction of C. elegans NAC∙60S. (Left) Cross section of the map to better visualize the NAC density in the tunnel is shown. (Right) Close-up view of the NAC density in the tunnel that reaches the constriction formed by the extension of uL22 is shown. The resolution of the NAC density inside the ribosomal tunnel is 6–8 A˚ . The map was low-pass filtered to 4.2-A˚ resolution. The residues R126 of uL22 and R28 of eL39 shown in the stick model were substituted with Bpa in the analyses shown in (C) and Figures S5A–S5C. (B) Site-specific photo-crosslinking of different Bpa-NAC variants (see Figure S4A) to stalled ribosome-nascent chain complexes (RNCs) car- rying in vitro translated, S35-labeled NCs with defined length (10–50 aas; translated substrate = human glucose-6-phosphate isomerase [GPI]). Autoradiograph images are shown. The peptidyl- tRNA (NC-tRNA) and position-specific NC-tRNA- NAC crosslinks (arrowheads) are indicated. (C) Engineered yeast 60S ribosomes carrying Bpa at tunnel-wall-lining position R126 of FLAG-uL22, indicated in (A), were photo-crosslinked to purified human and C. elegans (C.e.) NAC. WT-NAC as well as NAC deletion mutants lacking the N-terminal aNAC domain (C. elegans DN1–53 and human DN1–67) were used. FLAG, aNAC, and bNAC im- munoblots are shown. Red arrowheads indicate bNAC-specific crosslinks. Asterisk on FLAG blot marks a NAC-independent intra-60S ribosomal crosslink. See also Figures S5A–S5C. (D) Human NAC carrying Bpa at position 2 of bNAC (b-X2) was photo-crosslinked to puromycin- washed empty 60S or untreated full 80S. eL22, uL22, and eL39 immunoblots are shown. See also Figures S4 and S5.
Figure Legend Snippet: Figure 3. N-bNAC Probes Nascent Chains inside the Ribosomal Tunnel (A) cryo-EM reconstruction of C. elegans NAC∙60S. (Left) Cross section of the map to better visualize the NAC density in the tunnel is shown. (Right) Close-up view of the NAC density in the tunnel that reaches the constriction formed by the extension of uL22 is shown. The resolution of the NAC density inside the ribosomal tunnel is 6–8 A˚ . The map was low-pass filtered to 4.2-A˚ resolution. The residues R126 of uL22 and R28 of eL39 shown in the stick model were substituted with Bpa in the analyses shown in (C) and Figures S5A–S5C. (B) Site-specific photo-crosslinking of different Bpa-NAC variants (see Figure S4A) to stalled ribosome-nascent chain complexes (RNCs) car- rying in vitro translated, S35-labeled NCs with defined length (10–50 aas; translated substrate = human glucose-6-phosphate isomerase [GPI]). Autoradiograph images are shown. The peptidyl- tRNA (NC-tRNA) and position-specific NC-tRNA- NAC crosslinks (arrowheads) are indicated. (C) Engineered yeast 60S ribosomes carrying Bpa at tunnel-wall-lining position R126 of FLAG-uL22, indicated in (A), were photo-crosslinked to purified human and C. elegans (C.e.) NAC. WT-NAC as well as NAC deletion mutants lacking the N-terminal aNAC domain (C. elegans DN1–53 and human DN1–67) were used. FLAG, aNAC, and bNAC im- munoblots are shown. Red arrowheads indicate bNAC-specific crosslinks. Asterisk on FLAG blot marks a NAC-independent intra-60S ribosomal crosslink. See also Figures S5A–S5C. (D) Human NAC carrying Bpa at position 2 of bNAC (b-X2) was photo-crosslinked to puromycin- washed empty 60S or untreated full 80S. eL22, uL22, and eL39 immunoblots are shown. See also Figures S4 and S5.

Techniques Used: Cryo-EM Sample Prep, In Vitro, Labeling, Autoradiography, Western Blot

Figure 5. Sensing of De Novo Synthesized Nascent Chains by NAC Ribosome binding of NAC is mediated by a ribosome-binding regulatory arm (N-aNAC) and a translation sensor domain (N-bNAC). N-aNAC directly contacts the ribosome close to the tunnel exit but also possesses a ribosome binding inhibitory element that interacts with eL19. The empty tunnel of idle and early-stage translating ribosomes is sensed by N-bNAC, which inserts deeply into the ribosomal tunnel up to the constriction formed by uL22. In the tunnel-inserted conformation, NAC blocks the premature, unproductive ribosome association of Sec61 and likely of other cotranslational protein biogenesis factors, including RAC and SRP (left, early state). During polypeptide elongation, N-bNAC senses short nascent chains and is partially pushed out of the ribosomal tunnel, which likely repositions the NAC domain outside the tunnel (dotted arrows) to facilitate the early recruitment of other protein biogenesis factors, like SRP (middle, intermediate state). Once the N-bNAC tail is completely pushed out of the tunnel, it can relocate to an alternate binding site on the ribosome surface involving eL22 and eL31 (right, late stage). At this stage, NAC may orchestrate cotranslational protein folding and targeting processes by regulating the specific binding of other chaperones and targeting factors. MTS, mitochondrial targeting sequence; SS, endoplasmic reticulum signal sequence; TMD, transmembrane domain.
Figure Legend Snippet: Figure 5. Sensing of De Novo Synthesized Nascent Chains by NAC Ribosome binding of NAC is mediated by a ribosome-binding regulatory arm (N-aNAC) and a translation sensor domain (N-bNAC). N-aNAC directly contacts the ribosome close to the tunnel exit but also possesses a ribosome binding inhibitory element that interacts with eL19. The empty tunnel of idle and early-stage translating ribosomes is sensed by N-bNAC, which inserts deeply into the ribosomal tunnel up to the constriction formed by uL22. In the tunnel-inserted conformation, NAC blocks the premature, unproductive ribosome association of Sec61 and likely of other cotranslational protein biogenesis factors, including RAC and SRP (left, early state). During polypeptide elongation, N-bNAC senses short nascent chains and is partially pushed out of the ribosomal tunnel, which likely repositions the NAC domain outside the tunnel (dotted arrows) to facilitate the early recruitment of other protein biogenesis factors, like SRP (middle, intermediate state). Once the N-bNAC tail is completely pushed out of the tunnel, it can relocate to an alternate binding site on the ribosome surface involving eL22 and eL31 (right, late stage). At this stage, NAC may orchestrate cotranslational protein folding and targeting processes by regulating the specific binding of other chaperones and targeting factors. MTS, mitochondrial targeting sequence; SS, endoplasmic reticulum signal sequence; TMD, transmembrane domain.

Techniques Used: Synthesized, Binding Assay, Sequencing



Similar Products

97
ATCC l ul22 60s ribosomal protein l17 a b os saccharomyces cerevisiae
L Ul22 60s Ribosomal Protein L17 A B Os Saccharomyces Cerevisiae, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/l ul22 60s ribosomal protein l17 a b os saccharomyces cerevisiae/product/ATCC
Average 97 stars, based on 1 article reviews
l ul22 60s ribosomal protein l17 a b os saccharomyces cerevisiae - by Bioz Stars, 2026-03
97/100 stars
  Buy from Supplier

90
WuXi AppTec rabbit anti-ul22 (rpl17
Rabbit Anti Ul22 (Rpl17, supplied by WuXi AppTec, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti-ul22 (rpl17/product/WuXi AppTec
Average 90 stars, based on 1 article reviews
rabbit anti-ul22 (rpl17 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
WuXi AppTec ul22
( A ) <t>uL22</t> has three discernible states: scanning, engaged, or displaced. The maps shown are as follows: for the scanning state, the highest-resolution map available of a cytoplasmic ribosome from eukarya (EMD-40205); for the engaged state, the RAMP4-bound Sec61 map from this study, and for the displaced state, the multipass translocon (MPT)-bound map previously reported from this dataset (EMD-25994). For display, the maps were lowpass-filtered at 8 Å. ( B ) Alignment of select uL22 tail sequences. Underlines indicate the C-terminal helices annotated in the AF2 database. ( C ) Superposition of the animal and fungal uL22 tails (PDB 8AGX). ( D ) Structure of the uL22 SXKK motif, with hydrogen bonds indicated in cyan. ( E ) Comparison of the ribosome-translocon junction in the absence (top) and presence (bottom) of an ordered uL22 C-terminal helix. Note that the helix occludes the gate-side exit towards the cytoplasm.
Ul22, supplied by WuXi AppTec, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ul22/product/WuXi AppTec
Average 90 stars, based on 1 article reviews
ul22 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Momentive Performance Materials niax® ul22
( A ) <t>uL22</t> has three discernible states: scanning, engaged, or displaced. The maps shown are as follows: for the scanning state, the highest-resolution map available of a cytoplasmic ribosome from eukarya (EMD-40205); for the engaged state, the RAMP4-bound Sec61 map from this study, and for the displaced state, the multipass translocon (MPT)-bound map previously reported from this dataset (EMD-25994). For display, the maps were lowpass-filtered at 8 Å. ( B ) Alignment of select uL22 tail sequences. Underlines indicate the C-terminal helices annotated in the AF2 database. ( C ) Superposition of the animal and fungal uL22 tails (PDB 8AGX). ( D ) Structure of the uL22 SXKK motif, with hydrogen bonds indicated in cyan. ( E ) Comparison of the ribosome-translocon junction in the absence (top) and presence (bottom) of an ordered uL22 C-terminal helix. Note that the helix occludes the gate-side exit towards the cytoplasm.
Niax® Ul22, supplied by Momentive Performance Materials, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/niax® ul22/product/Momentive Performance Materials
Average 90 stars, based on 1 article reviews
niax® ul22 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

93
Proteintech ul22
Figure 3. N-bNAC Probes Nascent Chains inside the Ribosomal Tunnel (A) cryo-EM reconstruction of C. elegans NAC∙60S. (Left) Cross section of the map to better visualize the NAC density in the tunnel is shown. (Right) Close-up view of the NAC density in the tunnel that reaches the constriction formed by the extension of <t>uL22</t> is shown. The resolution of the NAC density inside the ribosomal tunnel is 6–8 A˚ . The map was low-pass filtered to 4.2-A˚ resolution. The residues R126 of uL22 and R28 of eL39 shown in the stick model were substituted with Bpa in the analyses shown in (C) and Figures S5A–S5C. (B) Site-specific photo-crosslinking of different Bpa-NAC variants (see Figure S4A) to stalled ribosome-nascent chain complexes (RNCs) car- rying in vitro translated, S35-labeled NCs with defined length (10–50 aas; translated substrate = human glucose-6-phosphate isomerase [GPI]). Autoradiograph images are shown. The peptidyl- tRNA (NC-tRNA) and position-specific NC-tRNA- NAC crosslinks (arrowheads) are indicated. (C) Engineered yeast 60S ribosomes carrying Bpa at tunnel-wall-lining position R126 of FLAG-uL22, indicated in (A), were photo-crosslinked to purified human and C. elegans (C.e.) NAC. WT-NAC as well as NAC deletion mutants lacking the N-terminal aNAC domain (C. elegans DN1–53 and human DN1–67) were used. FLAG, aNAC, and bNAC im- munoblots are shown. Red arrowheads indicate bNAC-specific crosslinks. Asterisk on FLAG blot marks a NAC-independent intra-60S ribosomal crosslink. See also Figures S5A–S5C. (D) Human NAC carrying Bpa at position 2 of bNAC (b-X2) was photo-crosslinked to puromycin- washed empty 60S or untreated full 80S. eL22, uL22, and eL39 immunoblots are shown. See also Figures S4 and S5.
Ul22, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ul22/product/Proteintech
Average 93 stars, based on 1 article reviews
ul22 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

90
Crompton Corporation fomrez®ul22 catalyst
Figure 3. N-bNAC Probes Nascent Chains inside the Ribosomal Tunnel (A) cryo-EM reconstruction of C. elegans NAC∙60S. (Left) Cross section of the map to better visualize the NAC density in the tunnel is shown. (Right) Close-up view of the NAC density in the tunnel that reaches the constriction formed by the extension of <t>uL22</t> is shown. The resolution of the NAC density inside the ribosomal tunnel is 6–8 A˚ . The map was low-pass filtered to 4.2-A˚ resolution. The residues R126 of uL22 and R28 of eL39 shown in the stick model were substituted with Bpa in the analyses shown in (C) and Figures S5A–S5C. (B) Site-specific photo-crosslinking of different Bpa-NAC variants (see Figure S4A) to stalled ribosome-nascent chain complexes (RNCs) car- rying in vitro translated, S35-labeled NCs with defined length (10–50 aas; translated substrate = human glucose-6-phosphate isomerase [GPI]). Autoradiograph images are shown. The peptidyl- tRNA (NC-tRNA) and position-specific NC-tRNA- NAC crosslinks (arrowheads) are indicated. (C) Engineered yeast 60S ribosomes carrying Bpa at tunnel-wall-lining position R126 of FLAG-uL22, indicated in (A), were photo-crosslinked to purified human and C. elegans (C.e.) NAC. WT-NAC as well as NAC deletion mutants lacking the N-terminal aNAC domain (C. elegans DN1–53 and human DN1–67) were used. FLAG, aNAC, and bNAC im- munoblots are shown. Red arrowheads indicate bNAC-specific crosslinks. Asterisk on FLAG blot marks a NAC-independent intra-60S ribosomal crosslink. See also Figures S5A–S5C. (D) Human NAC carrying Bpa at position 2 of bNAC (b-X2) was photo-crosslinked to puromycin- washed empty 60S or untreated full 80S. eL22, uL22, and eL39 immunoblots are shown. See also Figures S4 and S5.
Fomrez®Ul22 Catalyst, supplied by Crompton Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fomrez®ul22 catalyst/product/Crompton Corporation
Average 90 stars, based on 1 article reviews
fomrez®ul22 catalyst - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


( A ) uL22 has three discernible states: scanning, engaged, or displaced. The maps shown are as follows: for the scanning state, the highest-resolution map available of a cytoplasmic ribosome from eukarya (EMD-40205); for the engaged state, the RAMP4-bound Sec61 map from this study, and for the displaced state, the multipass translocon (MPT)-bound map previously reported from this dataset (EMD-25994). For display, the maps were lowpass-filtered at 8 Å. ( B ) Alignment of select uL22 tail sequences. Underlines indicate the C-terminal helices annotated in the AF2 database. ( C ) Superposition of the animal and fungal uL22 tails (PDB 8AGX). ( D ) Structure of the uL22 SXKK motif, with hydrogen bonds indicated in cyan. ( E ) Comparison of the ribosome-translocon junction in the absence (top) and presence (bottom) of an ordered uL22 C-terminal helix. Note that the helix occludes the gate-side exit towards the cytoplasm.

Journal: eLife

Article Title: Structural analysis of the dynamic ribosome-translocon complex

doi: 10.7554/eLife.95814

Figure Lengend Snippet: ( A ) uL22 has three discernible states: scanning, engaged, or displaced. The maps shown are as follows: for the scanning state, the highest-resolution map available of a cytoplasmic ribosome from eukarya (EMD-40205); for the engaged state, the RAMP4-bound Sec61 map from this study, and for the displaced state, the multipass translocon (MPT)-bound map previously reported from this dataset (EMD-25994). For display, the maps were lowpass-filtered at 8 Å. ( B ) Alignment of select uL22 tail sequences. Underlines indicate the C-terminal helices annotated in the AF2 database. ( C ) Superposition of the animal and fungal uL22 tails (PDB 8AGX). ( D ) Structure of the uL22 SXKK motif, with hydrogen bonds indicated in cyan. ( E ) Comparison of the ribosome-translocon junction in the absence (top) and presence (bottom) of an ordered uL22 C-terminal helix. Note that the helix occludes the gate-side exit towards the cytoplasm.

Article Snippet: The affinity-purified ribosome fraction was analysed by immunoblotting together with 1% of the starting microsomes using antibodies against the following antigens at the indicated dilutions: RAMP4 (Abcam #ab184571, which recognizes both RAMP4 homologs; 1:5000), uL22 (Abgent, AP9892b; 1:1000), Sec61β ( ; 1:10,000), TRAPα ( ; 1:5000), STT3A (Novus Biologicals, H00003703-M02; 1:1000), TMCO1 ( ; 1:5000), CCDC47 (Bethyl Laboratories, A305-100A; 1:2000), and NOMO (Invitrogen; PA5-47534; 1:1000).

Techniques: Comparison

( A ) The uL22 CTH is observed in a reported cryo-ET average from intact membranes, EMD-15884, and at a similar occupancy to the present dataset. A similar average of hibernating ribosomes (EMD-15889) contains abundant nascent chain-like density despite the lack of a P-site tRNA, and this density appears to compete with the uL22 CTH. ( B ) The uL22 CTH binds with a similar tilt and register in the two other reported structures where those details are discernible. For display, the Sec61-RAMP4 map was supersampled at half the original pixel size.

Journal: eLife

Article Title: Structural analysis of the dynamic ribosome-translocon complex

doi: 10.7554/eLife.95814

Figure Lengend Snippet: ( A ) The uL22 CTH is observed in a reported cryo-ET average from intact membranes, EMD-15884, and at a similar occupancy to the present dataset. A similar average of hibernating ribosomes (EMD-15889) contains abundant nascent chain-like density despite the lack of a P-site tRNA, and this density appears to compete with the uL22 CTH. ( B ) The uL22 CTH binds with a similar tilt and register in the two other reported structures where those details are discernible. For display, the Sec61-RAMP4 map was supersampled at half the original pixel size.

Article Snippet: The affinity-purified ribosome fraction was analysed by immunoblotting together with 1% of the starting microsomes using antibodies against the following antigens at the indicated dilutions: RAMP4 (Abcam #ab184571, which recognizes both RAMP4 homologs; 1:5000), uL22 (Abgent, AP9892b; 1:1000), Sec61β ( ; 1:10,000), TRAPα ( ; 1:5000), STT3A (Novus Biologicals, H00003703-M02; 1:1000), TMCO1 ( ; 1:5000), CCDC47 (Bethyl Laboratories, A305-100A; 1:2000), and NOMO (Invitrogen; PA5-47534; 1:1000).

Techniques: Tomography

Figure 3. N-bNAC Probes Nascent Chains inside the Ribosomal Tunnel (A) cryo-EM reconstruction of C. elegans NAC∙60S. (Left) Cross section of the map to better visualize the NAC density in the tunnel is shown. (Right) Close-up view of the NAC density in the tunnel that reaches the constriction formed by the extension of uL22 is shown. The resolution of the NAC density inside the ribosomal tunnel is 6–8 A˚ . The map was low-pass filtered to 4.2-A˚ resolution. The residues R126 of uL22 and R28 of eL39 shown in the stick model were substituted with Bpa in the analyses shown in (C) and Figures S5A–S5C. (B) Site-specific photo-crosslinking of different Bpa-NAC variants (see Figure S4A) to stalled ribosome-nascent chain complexes (RNCs) car- rying in vitro translated, S35-labeled NCs with defined length (10–50 aas; translated substrate = human glucose-6-phosphate isomerase [GPI]). Autoradiograph images are shown. The peptidyl- tRNA (NC-tRNA) and position-specific NC-tRNA- NAC crosslinks (arrowheads) are indicated. (C) Engineered yeast 60S ribosomes carrying Bpa at tunnel-wall-lining position R126 of FLAG-uL22, indicated in (A), were photo-crosslinked to purified human and C. elegans (C.e.) NAC. WT-NAC as well as NAC deletion mutants lacking the N-terminal aNAC domain (C. elegans DN1–53 and human DN1–67) were used. FLAG, aNAC, and bNAC im- munoblots are shown. Red arrowheads indicate bNAC-specific crosslinks. Asterisk on FLAG blot marks a NAC-independent intra-60S ribosomal crosslink. See also Figures S5A–S5C. (D) Human NAC carrying Bpa at position 2 of bNAC (b-X2) was photo-crosslinked to puromycin- washed empty 60S or untreated full 80S. eL22, uL22, and eL39 immunoblots are shown. See also Figures S4 and S5.

Journal: Molecular cell

Article Title: Early Scanning of Nascent Polypeptides inside the Ribosomal Tunnel by NAC.

doi: 10.1016/j.molcel.2019.06.030

Figure Lengend Snippet: Figure 3. N-bNAC Probes Nascent Chains inside the Ribosomal Tunnel (A) cryo-EM reconstruction of C. elegans NAC∙60S. (Left) Cross section of the map to better visualize the NAC density in the tunnel is shown. (Right) Close-up view of the NAC density in the tunnel that reaches the constriction formed by the extension of uL22 is shown. The resolution of the NAC density inside the ribosomal tunnel is 6–8 A˚ . The map was low-pass filtered to 4.2-A˚ resolution. The residues R126 of uL22 and R28 of eL39 shown in the stick model were substituted with Bpa in the analyses shown in (C) and Figures S5A–S5C. (B) Site-specific photo-crosslinking of different Bpa-NAC variants (see Figure S4A) to stalled ribosome-nascent chain complexes (RNCs) car- rying in vitro translated, S35-labeled NCs with defined length (10–50 aas; translated substrate = human glucose-6-phosphate isomerase [GPI]). Autoradiograph images are shown. The peptidyl- tRNA (NC-tRNA) and position-specific NC-tRNA- NAC crosslinks (arrowheads) are indicated. (C) Engineered yeast 60S ribosomes carrying Bpa at tunnel-wall-lining position R126 of FLAG-uL22, indicated in (A), were photo-crosslinked to purified human and C. elegans (C.e.) NAC. WT-NAC as well as NAC deletion mutants lacking the N-terminal aNAC domain (C. elegans DN1–53 and human DN1–67) were used. FLAG, aNAC, and bNAC im- munoblots are shown. Red arrowheads indicate bNAC-specific crosslinks. Asterisk on FLAG blot marks a NAC-independent intra-60S ribosomal crosslink. See also Figures S5A–S5C. (D) Human NAC carrying Bpa at position 2 of bNAC (b-X2) was photo-crosslinked to puromycin- washed empty 60S or untreated full 80S. eL22, uL22, and eL39 immunoblots are shown. See also Figures S4 and S5.

Article Snippet: Antibodies used throughout this study were FLAG (F7425, Sigma), uL16 (AP17603a, Abgent), eL19 (sc-100830, Santa Cruz), uL22 (14121-1-AP, Proteintech), eL22 (25002-1-AP, Proteintech), eL39 (14990-1-AP, Proteintech), uL4 (sc-100838, Santa Cruz), Gapdh (sc-137179, Santa Cruz), Actin (sc-47778, Santa Cruz), human aNAC (40-1000, Invitrogen), human bNAC (ab66940, Abcam), Puromycin (MABE343, Merck), HSP4/GRP78 (PA5-22967, Thermo Scientific), Sec61a (sc-393182, Santa Cruz), and PDI3 (kind gift of Antony Page, University of Glasgow, Scotland (Eschenlauer and Page, 2003)).

Techniques: Cryo-EM Sample Prep, In Vitro, Labeling, Autoradiography, Western Blot

Figure 5. Sensing of De Novo Synthesized Nascent Chains by NAC Ribosome binding of NAC is mediated by a ribosome-binding regulatory arm (N-aNAC) and a translation sensor domain (N-bNAC). N-aNAC directly contacts the ribosome close to the tunnel exit but also possesses a ribosome binding inhibitory element that interacts with eL19. The empty tunnel of idle and early-stage translating ribosomes is sensed by N-bNAC, which inserts deeply into the ribosomal tunnel up to the constriction formed by uL22. In the tunnel-inserted conformation, NAC blocks the premature, unproductive ribosome association of Sec61 and likely of other cotranslational protein biogenesis factors, including RAC and SRP (left, early state). During polypeptide elongation, N-bNAC senses short nascent chains and is partially pushed out of the ribosomal tunnel, which likely repositions the NAC domain outside the tunnel (dotted arrows) to facilitate the early recruitment of other protein biogenesis factors, like SRP (middle, intermediate state). Once the N-bNAC tail is completely pushed out of the tunnel, it can relocate to an alternate binding site on the ribosome surface involving eL22 and eL31 (right, late stage). At this stage, NAC may orchestrate cotranslational protein folding and targeting processes by regulating the specific binding of other chaperones and targeting factors. MTS, mitochondrial targeting sequence; SS, endoplasmic reticulum signal sequence; TMD, transmembrane domain.

Journal: Molecular cell

Article Title: Early Scanning of Nascent Polypeptides inside the Ribosomal Tunnel by NAC.

doi: 10.1016/j.molcel.2019.06.030

Figure Lengend Snippet: Figure 5. Sensing of De Novo Synthesized Nascent Chains by NAC Ribosome binding of NAC is mediated by a ribosome-binding regulatory arm (N-aNAC) and a translation sensor domain (N-bNAC). N-aNAC directly contacts the ribosome close to the tunnel exit but also possesses a ribosome binding inhibitory element that interacts with eL19. The empty tunnel of idle and early-stage translating ribosomes is sensed by N-bNAC, which inserts deeply into the ribosomal tunnel up to the constriction formed by uL22. In the tunnel-inserted conformation, NAC blocks the premature, unproductive ribosome association of Sec61 and likely of other cotranslational protein biogenesis factors, including RAC and SRP (left, early state). During polypeptide elongation, N-bNAC senses short nascent chains and is partially pushed out of the ribosomal tunnel, which likely repositions the NAC domain outside the tunnel (dotted arrows) to facilitate the early recruitment of other protein biogenesis factors, like SRP (middle, intermediate state). Once the N-bNAC tail is completely pushed out of the tunnel, it can relocate to an alternate binding site on the ribosome surface involving eL22 and eL31 (right, late stage). At this stage, NAC may orchestrate cotranslational protein folding and targeting processes by regulating the specific binding of other chaperones and targeting factors. MTS, mitochondrial targeting sequence; SS, endoplasmic reticulum signal sequence; TMD, transmembrane domain.

Article Snippet: Antibodies used throughout this study were FLAG (F7425, Sigma), uL16 (AP17603a, Abgent), eL19 (sc-100830, Santa Cruz), uL22 (14121-1-AP, Proteintech), eL22 (25002-1-AP, Proteintech), eL39 (14990-1-AP, Proteintech), uL4 (sc-100838, Santa Cruz), Gapdh (sc-137179, Santa Cruz), Actin (sc-47778, Santa Cruz), human aNAC (40-1000, Invitrogen), human bNAC (ab66940, Abcam), Puromycin (MABE343, Merck), HSP4/GRP78 (PA5-22967, Thermo Scientific), Sec61a (sc-393182, Santa Cruz), and PDI3 (kind gift of Antony Page, University of Glasgow, Scotland (Eschenlauer and Page, 2003)).

Techniques: Synthesized, Binding Assay, Sequencing